In a GWAS of phorias, we have identified one locus strongly associated with near horizontal phoria (P = 2.3 × 10−8; ppermuted = 0.014). The region containing the strongest association signal lies in the gene ALDH5A1. Independently, this gene is a very plausible candidate for being a source of variation in heterophoria and heterotropia.
ALDH5A1 encodes the mitochondrial aldehyde dehydrogenase (NAD+)-dependent enzyme succinic semialdehyde dehydrogenase (SSADH). This enzyme catalyzes the oxidation of succinic semialdehyde to succinate, the last operation in degradation of γ-aminobutyric acid (GABA).
ALDH5A1, has two major alternative transcripts, and a single promoter region.
38 Blasi and colleagues
38 have suggested that various missense mutations in
ALDH5A1 may contribute to individual variability in SSADH activity.
Mutations of
ALDH5A1 cause the rare (and probably under-reported
39 ) recessively inherited disorder succinic semialdehyde dehydrogenase deficiency, otherwise known as gamma-hydroxybutyric aciduria.
40–44 In GABA degradation, without SSADH, transamination of GABA to succinic semialdehyde is followed by reduction to the neuropharmacologically active compound 4-hydroxybutyric acid (GHB). GHB is found normally as a minor metabolite of GABA, but builds up, with GABA, in the brains of those suffering from SSADH deficiency.
The clinical features of SSADH deficiency include mental retardation, delayed language and motor development, hypotonia, seizures, behavioral problems, ataxia, and hyporeflexia.
45,46 Especially pertinent to the present study is the fact that SSADH deficiency has been associated with strabismus.
45,46 However, owing to the rarity of SSADH deficiency (only a few hundred cases worldwide), most reports are of single cases or of a small number of cases. It is therefore difficult to assess accurately the incidence of strabismus in SSADH deficiency, especially since it may be omitted from case reports to give precedence to the more debilitating clinical features of the disorder.
Also linking
ALDH5A1 to strabismus is valproic acid. Valproic acid is used as a drug to increase levels of GABA, probably by inhibiting SSADH.
47,48 Exposure to valproic acid in utero causes fetal valproate syndrome, associated with a number of abnormalities, which include strabismus.
49,50
ALDH5A1 knockout mice have been studied as a model for SSADH deficiency. The mice show ataxia, seizures, and failure to thrive. Seizures are lethal around postnatal day 25.
51 The brains of the knockout mice have increased levels of GABA and decreased levels of glutamine,
52 and show reduced expression and impaired function of GABA(A) and GABA(B) receptors,
53 myelin abnormalities,
54 and lipid abnormalities.
55 ALDH5A1 knockout mice can be partially rescued by administration of vigabatrin, NCS382 (a GHB receptor antagonist), CHP 25348 (a GABA[B] receptor antagonist), taurine, and a ketogenic diet.
56
Variation in
ALDH5A1 has been associated with clinical conditions other than SSADH deficiency, including schizophrenia,
57,58 mild developmental delay accompanied by increased SSADH activity,
59 and epilepsy,
60,61 Variations in the gene
ALDH5A1 in normal, healthy adults have been associated with intelligence,
62,63 and with cognitive functioning and survival in old age.
64
Though the pathway by which
ALDH5A1 might influence ocular alignment is unclear, we can suggest one possibility. It has been suggested that one factor in the etiology of strabismus might be delayed myelination, causing early disturbance of oculomotor reflexes.
65,66 Variation in
ALDH5A1 may cause variation in myelination, since knockout mice have myelin abnormalities.
The three other genes present in the region identified by clustering are
MRS2,
GPLD1, and
KIAA0319. MRS2 encodes a magnesium transporter protein thought to mediate the influx of magnesium ions into the mitochondrial matrix.
67 GPLD1 encodes a phospholipase that leads to the release of proteins anchored by phosphatidylinositol glycans from attachment to plasma membranes.
68 Neither is an obvious candidate for variation in phorias.
KIAA0319 encodes a transmembrane protein involved in neuronal migration during brain development.
69 Its association with dyslexia has given it the alias
Dyslexia Susceptibility 2 (
DYLX2).
KIAA0319 is associated with alterations in white matter: knockdown mice have a reduction in the midsagittal area of the corpus callosum,
70 and variation in
KIAA0319 in humans is associated with variation in white matter volume in the temporoparietal region.
71 Since the innervation of ocular muscles might be a factor in the etiology of phorias,
KIAA0319 is also a plausible candidate for causing variation in phorias. We note that phoria and strabismus have sometimes been associated with dyslexia,
72 and dyslexia has been controversially treated using prisms.
73 However, there are also reports that dyslexia is not associated with the presence of binocular abnormalities.
74,75